SH2D1A and B-cell non-Hodgkin lymphoma: Yet, the observation that 5 of 158 males presenting with B-cell NHL (3.2%) had SH2D1A mutations raises the issue of prospective screening for XLP-1 in males with B-cell lymphoma (126).